3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
10
Phase 1/2
4
Phase 1
4
Phase EARLY_PHASE1
1
Phase 4
1
Phase 3
1
Status
Completed
12
Withdrawn
1
Unknown
1
Terminated
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Interventions
Cisplatin
130
Radiotherapy
94
Carboplatin
85
Paclitaxel
78
Fluorouracil
78
Cyclophosphamide
77
Gemcitabine
72
Capecitabine
66
Docetaxel
65
Doxorubicin
60
Oxaliplatin
59
Etoposide
57
Leucovorin
49
Vincristine
47
Chemotherapy, Adjuvant
42
Cytarabine
38
Dexamethasone
35
Drug Therapy
33
Bevacizumab
30
Epirubicin
29
Neoadjuvant Therapy
28
Pemetrexed
27
Tamoxifen
25
Prednisone
24
Irinotecan
24
Rituximab
21
Methotrexate
21
Radiotherapy, Intensity-Modulated
19
apatinib
18
Vinorelbine
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Unknown
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
Clear all
NCT00091676
2012-02-03
BiovaxID
Biovest International
Phase 3
Unknown
629 enrolled